Personalized vaccine tested to stop aggressive breast cancer from coming back
NCT ID NCT02063724
Summary
This early-stage study tested a personalized vaccine designed to teach the immune system to attack breast cancer cells, aiming to prevent the cancer from returning. It involved 15 women with a high-risk form of breast cancer who had no detectable disease after initial treatment. The main goals were to check if the vaccine was safe to make and administer, and to see if it triggered an immune response.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.